By: June Chen, MD
The U.S. Food and Drug Administration (FDA) has notified patients and healthcare professionals of a voluntary nationwide recall of all GlucoPro Insulin Syringes by the manufacturer, Nipro Medical Corporation. The reason for the recall is that the insulin syringes may have needles that detach from the syringe itself.
If the needles become detached from the insulin syringes during use, they can become stuck in the insulin vial, push back into the syringe, or remain in the patient’s skin after injection. According to the manufacturer, no injuries have been reported to date in relation to these defective insulin syringes. The voluntary recall includes all products codes and lot numbers with expiration dates before November 1, 2011. These insulin syringes were distributed throughout the U.S. and Puerto Rico.
Consumers who have these insulin syringes are advised to stop using them immediately and to return them to the seller for reimbursement. In addition, the manufacturer is notifying its distributors and arranging for return of all recalled insulin syringes.
FDA MedWatch Web site.